These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 19719333)

  • 21. Potential for interaction of kava and St. John's wort with drugs.
    Singh YN
    J Ethnopharmacol; 2005 Aug; 100(1-2):108-13. PubMed ID: 16005588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction.
    Izzo AA; Di Carlo G; Borrelli F; Ernst E
    Int J Cardiol; 2005 Jan; 98(1):1-14. PubMed ID: 15676159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperforin in St. John's wort drug interactions.
    Madabushi R; Frank B; Drewelow B; Derendorf H; Butterweck V
    Eur J Clin Pharmacol; 2006 Mar; 62(3):225-33. PubMed ID: 16477470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Potential risks, adverse effects and drug interactions associated with herbal medicine in dental patients].
    Zlotogorski Hurvitz A; Littner M
    Refuat Hapeh Vehashinayim (1993); 2004 Apr; 21(2):25-41, 97. PubMed ID: 15503544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics.
    Gurley BJ; Swain A; Williams DK; Barone G; Battu SK
    Mol Nutr Food Res; 2008 Jul; 52(7):772-9. PubMed ID: 18214850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P450 enzyme mediated herbal drug interactions (Part 1).
    Wanwimolruk S; Prachayasittikul V
    EXCLI J; 2014; 13():347-91. PubMed ID: 26417265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of the effects of herbal medicines on warfarin response in healthy subjects: a population pharmacokinetic-pharmacodynamic modeling approach.
    Jiang X; Blair EY; McLachlan AJ
    J Clin Pharmacol; 2006 Nov; 46(11):1370-8. PubMed ID: 17050802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ
    Br J Clin Pharmacol; 2004 May; 57(5):592-9. PubMed ID: 15089812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
    Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
    Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDR- and CYP3A4-mediated drug-herbal interactions.
    Pal D; Mitra AK
    Life Sci; 2006 Mar; 78(18):2131-45. PubMed ID: 16442130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic interactions between herbal remedies and medicinal drugs.
    Ioannides C
    Xenobiotica; 2002 Jun; 32(6):451-78. PubMed ID: 12160480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.
    Henderson L; Yue QY; Bergquist C; Gerden B; Arlett P
    Br J Clin Pharmacol; 2002 Oct; 54(4):349-56. PubMed ID: 12392581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4.
    Dürr D; Stieger B; Kullak-Ublick GA; Rentsch KM; Steinert HC; Meier PJ; Fattinger K
    Clin Pharmacol Ther; 2000 Dec; 68(6):598-604. PubMed ID: 11180019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herbal supplements and therapeutic drug monitoring: focus on digoxin immunoassays and interactions with St. John's wort.
    Dasgupta A
    Ther Drug Monit; 2008 Apr; 30(2):212-7. PubMed ID: 18367983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
    Barnes J; Anderson LA; Phillipson JD
    J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of Therapeutic Drug Monitoring in Identifying Clinically Significant Interactions Between St. John's Wort and Prescription Drugs.
    Steenkamp V; Parkar H; Dasgupta A
    Ther Drug Monit; 2023 Feb; 45(1):35-44. PubMed ID: 36624575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P450 enzyme mediated herbal drug interactions (Part 2).
    Wanwimolruk S; Phopin K; Prachayasittikul V
    EXCLI J; 2014; 13():869-96. PubMed ID: 26417310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy.
    Fasinu PS; Gurley BJ; Walker LA
    Curr Drug Metab; 2015; 17(1):52-64. PubMed ID: 26526838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug interactions with phytotherapeutics in oncology.
    Haefeli WE; Carls A
    Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):359-77. PubMed ID: 24387348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herbal medicines and perioperative care.
    Ang-Lee MK; Moss J; Yuan CS
    JAMA; 2001 Jul; 286(2):208-16. PubMed ID: 11448284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.